Two new reports from the Treatment Action Group highlight the underfunding of scientific research on tuberculosis and related diseases.
The first report is aptly called “Flat-Lined,” and it shows that funding for the National Institutes of Health from 2004 to 2009 has not kept up with inflation, translating into a net dip in research investment for all diseases.
The bottom line, the TAG report concludes, is that innovation is discouraged and opportunities missed in the treatment of HIV/AIDS, tuberculosis and other diseases that heavily impact patients with HIV.
A second report by TAG focuses exclusively on tuberculosis research funding and finds that while TB research has inched up slightly in recent years, it falls “far short” of the level needed to reach World Health Organization targets for TB control.
Click here to get the TAG reports.